Lundbeck
Joerg Hornstein is an accomplished executive with extensive experience in finance and management within the pharmaceutical and consumer goods sectors. Currently serving as Executive Vice President and Chief Financial Officer at Lundbeck since August 2022, Joerg Hornstein plays a critical role in driving business competitiveness and strategic direction while managing investor relations. Previously, Joerg held similar EVP and CFO roles at AC Immune and significant positions at Unternehmensgruppe Theo Müller, Merck KGaA, and EMD Millipore. Holding an MBA with Distinction from London Business School and a Bachelor of Business Administration in Finance from Baylor University, Joerg Hornstein has consistently demonstrated expertise in financial strategy, corporate finance, and operational management.
Lundbeck
42 followers
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at disease areas such as depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.